XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

138 hedge funds and large institutions have $1.18B invested in Acceleron Pharma Inc. in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 45 reducing their positions, and 15 closing their positions.

Holders
138
Holders Change
+2
Holders Change %
+1.47%
% of All Funds
3.69%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
17
Increased
46
Reduced
45
Closed
15
Calls
$2.19M
Puts
$2.68M
Net Calls
-$490K
Net Calls Change
+$2.92M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$29.4M
2
LCM
2
Laurion Capital Management
New York
$25M
3
Goldman Sachs
3
Goldman Sachs
New York
$30.2M
4
RCM
4
RA Capital Management
Massachusetts
$11.5M
5
HIM
5
Hillhouse Investment Management
Cayman Islands
$10.9M

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
PAMU
2
Pictet Asset Management (UK)
United Kingdom
$17M
3
CS
3
Credit Suisse
Switzerland
$7.48M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$6.13M
5
ORI
5
Oak Ridge Investments
Illinois
$44.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
CFA
151
Camarda Financial Advisors
Florida
– -$17K -500 Closed
Northwestern Mutual Wealth Management
152
Northwestern Mutual Wealth Management
Wisconsin
– -$6K -171 Closed
MWP
153
MYCIO Wealth Partners
Pennsylvania
– -$2K -45 Closed
3 4 5 6
7